Ensysce Biosciences, Inc. (ENSC)의 가격은 얼마입니까?

Ensysce Biosciences, Inc. (ENSC)의 가격은 $0.5275입니다.

Ensysce Biosciences, Inc. (ENSC)의 시가 총액은 무엇입니까?

Ensysce Biosciences, Inc. (ENSC)의 시가 총액은 $1.25M입니다.

Ensysce Biosciences, Inc. (ENSC) 액면분할

Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection platform, an abuse-resistant opioid prodrug technology; and Multi-Pill Abuse Resistance platform, an over-dose protection opioid prodrug technology. The company is developing PF614, a TAAP prodrug candidate of oxycodone, which is in Phase II clinical trial for the treatment of acute or chronic pain; and PF614-MPAR, a combination product of PF614 and nafamostat that is in Phase I clinical trial for overdose protection against excessive oral ingestion, as well as an oral and inhalation drug product of nafamostat for use against coronaviral infections and other pulmonary diseases, such as cystic fibrosis. It is also developing PF329, an extended-release prodrug of hydromorphone that is similar to PF614; PF8001 and PF8026 are extended and immediate-release prodrugs of amphetamine for ADHD medication abuse; and PF26810, an extended-release prodrug of methadone for opioid use disorder. The company is based in La Jolla, California.

연도	주식 분할	배수	누적 배수
2024-12-06	1:15	x0.066666666666667	x0.00027777777777778
2023-03-31	1:12	x0.083333333333333	x0.0041666666666667
2022-10-28	1:20	x0.05	x0.05

연도

주식 분할

배수

누적 배수

2024-12-06

1:15

x0.066666666666667

x0.00027777777777778

2023-03-31

1:12

x0.083333333333333

x0.0041666666666667

2022-10-28

1:20

x0.05

회사	주식 분할 횟수	누적 배수	국가
Novo Nordisk A/S NVO.US	5	x199	DK
Vertex Pharmaceuticals Incorporated VRTX.US	1	x2	US
Regeneron Pharmaceuticals, Inc. REGN.US	0	-	US
UCB SA UCB.BR	0	-	BE
CSL Limited CSL.AX	1	x3	AU

회사

주식 분할 횟수

누적 배수

국가